Video Source: "Economic New Observations" Report by Guangxi Broadcasting Television News Channel

On April 29, the 2025 International Medical Innovation Cooperation Forum opened in Fangchenggang City, where over 20 high-tech enterprises specializing in "AI + Healthcare" showcased their R&D achievements. Shanghai Nahefa Health Technology Co., Ltd. unveiled the global debut of its self-developed "Grand Master" Medical Multimodal Vertical Large Model v4.0 (hereinafter referred to as the latest version of the "Grand Master" Medical Large Model) at the forum.

As a major breakthrough in the intelligent transformation of traditional Chinese medicine (TCM), the latest version of the "Grand Master" Medical Large Model injects fresh momentum into Shanghai Nahefa Health’s Smart TCM Ecosystem Solutions. By deeply optimizing its core algorithms and training framework, the model achieves a leap forward in TCM AI engine performance, significantly enhancing diagnostic accuracy and treatment recommendation precision. Its robust multi-scenario adaptability demonstrates exceptional capabilities in natural language understanding, knowledge transfer, and logical reasoning.

Within the Smart TCM ecosystem, the model empowers critical domains such as intelligent auxiliary diagnosis and treatment, TCM health management, and scientific research innovation. Leveraging cutting-edge generative AI technologies, it addresses industry pain points like the subjective nature of TCM syndrome differentiation and fragmented knowledge systems. Its applications not only drive the deep integration of TCM theory with modern information technology but also establish a solid technological foundation for the modernization and intelligent advancement of TCM, offering scientific and efficient solutions for inheriting and innovating TCM practices. The launch of this innovation marks Shanghai Nahefa Health’s unwavering commitment to propelling TCM into a new era of intelligence and precision, opening broader horizons for promoting TCM culture globally.

Seizing this opportunity, Shanghai Nahefa Health aims to build an internationally competitive Smart TCM brand. In the future, the company plans to establish its headquarters in the Fangchenggang International Medical Open Experimental Zone, extending coverage to healthcare institutions across Guangxi with a focus on empowering grassroots medical facilities. The network will also radiate to ASEAN and SCO member states. Additionally, the company is planning the Guangxi TCM Big Data Innovation Center, which is expected to provide tens of millions of high-quality medical data resources for Guangxi, creating data assets worth billions to support cross-border medical collaboration and industrial innovation.